Molecular biology of esophageal squamous cell carcinoma.
暂无分享,去创建一个
[1] G. Plowman,et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Tsujitani,et al. Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. , 1997, Oncology.
[3] S. Groshen,et al. High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach , 1997, Oncogene.
[4] M. Oka,et al. CYFRA 21‐1 is a useful marker for esophageal squamous cell carcinoma , 1997, Cancer.
[5] Y. Tachimori,et al. Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. , 1997, Japanese journal of clinical oncology.
[6] M. Imamura,et al. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. , 1991, Cancer research.
[7] K. Chow,et al. p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis. , 1998, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.
[8] R. Metcalf,et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. , 1991, Cancer research.
[9] M. Redston,et al. p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival. , 1998, Molecular pathology : MP.
[10] A. Rustgi,et al. The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma. , 1996, Oncogene.
[11] B. Nordlinger,et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] A. Rustgi,et al. Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines. , 1997, Cancer letters.
[13] Patricia L. Blount,et al. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Toi,et al. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer , 1991, Cancer.
[15] M. Younes,et al. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] H. Sakamoto,et al. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. , 1993, Biochemical and biophysical research communications.
[17] P. Validire,et al. Human papillomavirus infection in esophageal squamous‐cell carcinoma in western countries , 1992, International journal of cancer.
[18] Y. Sasaguri,et al. Production onf matrix metalloproteinase‐2 and metalloproteinase‐3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study , 1992, Cancer.
[19] R. Hardwick,et al. Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[20] C. Chang,et al. Expression of multiple oncogenes in human esophageal carcinomas. , 1994, Cancer investigation.
[21] R. White,et al. MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. , 1991, Oncogene.
[22] N. Day,et al. Oesophageal cancer in never‐smokers and never‐drinkers , 1995, International journal of cancer.
[23] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[24] M. Feith,et al. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma , 1998, Cancer.
[25] M. Imamura,et al. Allelotype analysis of esophageal squamous cell carcinoma. , 1994, Cancer research.
[26] S. Bhambhani,et al. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer. , 1998, Indian journal of experimental biology.
[27] M. Saegusa,et al. Expression of bcl‐2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis , 1997, Cancer.
[28] P. I. Reed,et al. The Changing Incidence of Oesophageal Cancer , 1993, Endoscopy.
[29] A. van der Gaast,et al. 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus. , 1997, European journal of cancer.
[30] A. Rustgi,et al. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. , 1995, Oncogene.
[31] T. Sugimura,et al. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. , 1989, Cancer research.
[32] T. Kawano,et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. , 1997, Journal of clinical gastroenterology.
[33] A. Khurshid,et al. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. , 1998, JPMA. The Journal of the Pakistan Medical Association.
[34] A. Rustgi,et al. Human cyclin D1 oncogene and esophageal squamous cell carcinoma , 1995, Cancer.
[35] S. Seeber,et al. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities , 1999, International journal of cancer.
[36] M. Kitajima,et al. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] J. Wong,et al. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? , 1997, European journal of cancer.
[38] Y. Sasaguri,et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. , 1992, Cancer.
[39] T. Sugimura,et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. , 1994, Biochemical and biophysical research communications.
[40] J. Nesland,et al. Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas. , 1995, Anticancer research.
[41] Janusz Jankowski,et al. Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma , 1998 .
[42] J. Ferlay,et al. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden , 1993, International journal of cancer.
[43] S. Tsao,et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. , 1997, Human pathology.
[44] R. Ralhan,et al. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] S. Wilczynski,et al. Human papillomavirus (HPV) in head and neck cancer , 1997, Cancer.
[46] M. Yano,et al. CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus , 1997, International journal of cancer.
[47] K. Syrjänen,et al. Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous‐cell carcinomas by in situ hybridization , 1993, International journal of cancer.
[48] R. Chetty,et al. Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma. , 1997, Molecular pathology : MP.
[49] M. Kitajima,et al. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] H. Hausen,et al. Human papillomaviruses. , 1994, Annual review of microbiology.
[51] R. Odze,et al. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. , 1997, Human pathology.
[52] J. Yokota,et al. AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.
[53] J. Wong,et al. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. , 1996, Journal of clinical pathology.
[54] H. Sasano,et al. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification , 1994, Cancer.
[55] Y. Doki,et al. E-Cadherin and α-Catenin Expression in Human Esophageal Cancer , 1994 .
[56] E. Thiel,et al. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. , 1996, Journal of molecular medicine.
[57] H. Gabbert,et al. Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] D. Lin,et al. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[59] K. Orita,et al. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. , 1995, Anticancer research.
[60] M. Monden,et al. Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.
[61] J. Icenogle,et al. Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska natives , 1997, International journal of cancer.
[62] M. Rugge,et al. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[63] D. Birnbaum,et al. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. , 1995, British Journal of Cancer.
[64] R. Willers,et al. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. , 1996, British Journal of Cancer.
[65] N. Shimizu,et al. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas , 1989, Cancer.
[66] K. Lam,et al. Pathology of esophageal cancers: local experience and current insights. , 1997, Chinese medical journal.
[67] S. Mori,et al. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. , 1994, Cancer research.
[68] K. Lam,et al. C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[69] D. Rosenthal,et al. Cell Adhesion Molecules , 1991, International journal of dermatology.
[70] J. McKay,et al. Matrix metalloproteinase‐1 is associated with poor prognosis in oesophageal cancer , 1998, The Journal of pathology.
[71] Y. Yamashita,et al. Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. , 1998, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[72] Y. Doki,et al. Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. , 1998, International journal of oncology.
[73] K. Somers,et al. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.
[74] M. Hollstein,et al. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[75] S. Law,et al. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patients , 1997, International journal of cancer.
[76] Simon Law,et al. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients , 1999, American Journal of Gastroenterology.
[77] T. Gansler,et al. Differential Polymerase Chain Reaction Assay of Cyclin Dl Gene Amplification in Esophageal Carcinoma , 1994, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[78] Y. Nimura,et al. Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking , 1997, Cancer.
[79] K. Sugimachi,et al. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. , 1994, Archives of pathology & laboratory medicine.
[80] M. Hollstein,et al. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas , 1996, International journal of cancer.
[81] K. Sugimachi,et al. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer. , 1995, European Journal of Surgical Oncology.
[82] C. Fenoglio-Preiser,et al. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. , 1997, Human pathology.
[83] Y. Sasaguri,et al. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. , 1993, British Journal of Cancer.
[84] H. Yamamoto,et al. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. , 1998, International journal of oncology.
[85] M. Sur,et al. The role of the human papilloma virus in esophageal cancer , 1998, Pathology.
[86] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[87] M. Imamura,et al. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[88] R. Morgan,et al. Human papillomavirus and oesophageal squamous cell carcinoma in the UK. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[89] Y. Doki,et al. Cytoplasmic β‐catenin in esophageal cancers , 1999 .
[90] A. Burgess,et al. The Sixth George Swanson Christie Memorial Lecture: Growth Factors And Their Receptors: New Opportunities For Cancer Treatment , 1994, Pathology.
[91] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[92] H. Sasano,et al. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. , 1993, Anticancer research.
[93] C. D'Arrigo,et al. Cell adhesion molecules in oesophageal epithelium. , 1994, Gut.
[94] P. Dickens,et al. Transient detection of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection. , 1995 .
[95] T. McDaniel,et al. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. , 1993, Cancer research.
[96] H. Saya,et al. The CD44 adhesion molecule and metastasis. , 1994, Critical reviews in oncogenesis.
[97] M. Monden,et al. Beta-catenin expression in human cancers. , 1996, The American journal of pathology.
[98] R. Willers,et al. bcl‐2 expression and prognosis in squamous‐cell carcinomas of the esophagus , 1996, International journal of cancer.
[99] T. Walsh,et al. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy , 1994 .
[100] I. Weinstein,et al. Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.
[101] P. V. van Helden,et al. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high‐incidence area in South Africa , 1998, International journal of cancer.
[102] G. Yang,et al. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. , 1999, Carcinogenesis.
[103] K. Hirokawa,et al. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas , 1997, Virchows Archiv.
[104] S. Hirohashi,et al. Expression of E-Cadherin, α-Catenin, β-Catenin and Plakoglobin in Esophageal Carcinomas and Its Prognostic Significance , 1997 .
[105] J. Wong,et al. Prognostic implication of proliferative markers MIB‐1 and PC10 in esophageal squamous cell carcinoma , 1996, Cancer.
[106] Patricia L. Blount,et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.
[107] S. Seeber,et al. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[108] H. Gabbert,et al. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[109] M. Arima,et al. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers. , 1998, Oncology reports.
[110] T. Hattori,et al. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. , 1995, The American journal of pathology.
[111] L. Matrisian,et al. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts , 1986, Molecular and cellular biology.
[112] Ruggero Montesano,et al. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review , 1996, International journal of cancer.
[113] R. Poczatek,et al. CD44 expression in dysplastic epithelium and squamous‐cell carcinoma of the esophagus , 1996, International journal of cancer.
[114] L. Signorello,et al. Life‐style factors and medical conditions in relation to esophageal cancer by histologic type in a low‐risk population , 1996, International journal of cancer.
[115] S. J. Darnton,et al. Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade. , 1996, Journal of clinical pathology.
[116] M. Rugge,et al. bcl‐2 and p53 immunophenotypes in pre‐invasive, early and advanced oesophageal squamous cancer , 1997, Histopathology.
[117] M. Koike,et al. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of Ki‐67 and p53 antigen in relation to histopathologic findings , 1996, Cancer.
[118] Johannes Gerdes,et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.
[119] M. Saegusa,et al. Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. , 1997, Molecular pathology : MP.
[120] M. Imamura,et al. Analysis of gene amplification and overexpression in human esophageal‐carcinoma cell lines , 1994, International journal of cancer.
[121] R. Veale,et al. Amplification and expression of the TGF-α, EGF receptor and c-myc genes in four human oesophageal squamous cell carcinoma lines , 1993, Bioscience reports.
[122] A. Niendorf,et al. Expression and prognostic significance of immunoregulatory molecules in esophageal cancer , 1997, International journal of cancer.
[123] Y. Ikeda,et al. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. , 1996, Annals of Thoracic Surgery.
[124] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[125] E. Tahara,et al. EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors , 1990 .
[126] T. Aikou,et al. Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. , 1997, British Journal of Cancer.
[127] R. Eddy,et al. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. , 1993, Oncogene.
[128] M. Kaminishi,et al. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. , 1998, Hepato-gastroenterology.
[129] S. Tsao,et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation , 1997, International journal of cancer.
[130] R. Giavazzi,et al. Matrix metalloproteinase inhibition: a review of anti-tumour activity. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[131] S. Maeda,et al. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study. , 1993, Asian Pacific journal of allergy and immunology.
[132] M. Imamura,et al. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous‐cell‐carcinoma cell lines , 1997, International journal of cancer.
[133] K. Sugimachi,et al. Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. , 1997, International journal of oncology.
[134] E. de Villiers,et al. Papillomavirus in esophageal papillomas and carcinomas , 1999, International journal of cancer.
[135] F. Grabellus,et al. Expression of Bax, a pro‐apoptotic member of the Bcl‐2 family, in esophageal squamous cell carcinoma , 1997, International journal of cancer.
[136] D. Hernandez-Verdun,et al. The nucleolus and the nucleolar organizer regions , 1986, Biology of the cell.
[137] A. Brichet,et al. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. , 1996, The Annals of thoracic surgery.
[138] A. West,et al. Type 73 human papillomavirus in esophageal squamous cell carcinoma: A novel association , 1996, Cancer.
[139] M. Furihata,et al. Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinoma , 1998, International journal of cancer.
[140] D. Skinner,et al. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma , 1990, Journal of surgical oncology.
[141] C. Fenoglio-Preiser,et al. Detection of human papillomavirus in esophageal squamous cell carcinoma , 1996, Cancer.
[142] W. Chen,et al. Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[143] L. Billingham,et al. Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance. , 1997, Journal of clinical pathology.
[144] N. Muñoz. Epidemiological Aspects of Oesophageal Cancer , 1993, Endoscopy.
[145] G. Hannon,et al. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. , 1995, Human molecular genetics.
[146] M. Posner,et al. Apoptosis in esophageal cancer following induction chemoradiotherapy. , 1998, The Journal of surgical research.
[147] D. Parkin,et al. Patterns of Cancer in Five Continents , 1990, British Journal of Cancer.
[148] C. Harris,et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[149] Y. Doki,et al. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. , 1997, Carcinogenesis.
[150] M. Furihata,et al. Relationship between H-ras p21 product and p53 protein or high-risk human papillomaviruses in esophageal cancer from Kochi, Japan. , 1994, The American journal of gastroenterology.
[151] J. Abraham,et al. The MTS1 gene is frequently mutated in primary human esophageal tumors. , 1994, Oncogene.
[152] E. de Villiers,et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China , 1999, International journal of cancer.
[153] M. Cravo,et al. High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction , 1995, Cancer.
[154] G. Thomas,et al. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers , 1997, International journal of cancer.
[155] S. Fukushima,et al. Prognostic significance of the MIB‐1 proliferation index for patients with squamous cell carcinoma of the esophagus , 1995, Cancer.
[156] S. Mori,et al. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies. , 1992, Anticancer research.
[157] S. Syrjänen,et al. p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. , 1997, Anticancer research.
[158] A. Marchetti,et al. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[159] Y. Naomoto,et al. Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein. , 1996, Japanese journal of clinical oncology.
[160] S. Nishizuka,et al. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. , 1996, Cancer research.
[161] Y. Yuasa,et al. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. , 1994, Cancer research.
[162] M. Poljak,et al. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. , 1998, Human pathology.
[163] S. Mori,et al. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. , 1994, Cancer research.
[164] S. Kitano,et al. Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer. , 1998, Oncology reports.
[165] S. Law,et al. Use of flow cytometry in the analysis of stage III squamous cell carcinoma of the oesophagus and its association with MIB-1. , 1996, Journal of Clinical Pathology.
[166] L. Wang,et al. No evidence for the amplifications of MDM2 and C-myc genes involved in the genetic susceptibility to esophageal cancer in a high-risk area of north China. , 1996, Cancer genetics and cytogenetics.
[167] I. Pastan,et al. Frequent expression of the tumor antigen cak1 in squamous‐cell carcinomas , 1992, International journal of cancer.
[168] M. Pignatelli,et al. The molecular histology of neoplasia: the role of the cadherin/catenin complex , 1997, Histopathology.
[169] M. Rugge,et al. p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. , 1998, Molecular pathology : MP.
[170] P. Chikhlikar,et al. Clinical significance of p53, nm23, and bcl‐2 in T3–4N1M0 oesophageal carcinoma: An immunohistochemical approach , 1997, Journal of surgical oncology.
[171] K. Nooter,et al. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. , 1997, European Journal of Cancer.
[172] Y. Kitagawa,et al. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. , 1991, Cancer research.
[173] H. Sakamoto,et al. Amplified genes in cancer in upper digestive tract. , 1993, Seminars in cancer biology.
[174] S. J. Darnton,et al. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. , 1995, Journal of clinical pathology.
[175] T. Akiyama,et al. Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumors , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.
[176] M. Tsao,et al. ras mutation and expression of the ras‐regulated genes osteopontin and cathepsin L in human esophageal cancer , 1997, International journal of cancer.
[177] G. Yang,et al. Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high‐risk area in northern China , 1997, International journal of cancer.
[178] H. Sabe,et al. Expression of the c-myc gene in human gastrointestinal malignancies. , 1987, Biochemical and biophysical research communications.
[179] M. Lung,et al. p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong. , 1997, Cancer letters.
[180] M. Furihata,et al. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. , 1998, British Journal of Cancer.
[181] S. Yoshida,et al. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. , 1996, Japanese journal of clinical oncology.
[182] F. Puglisi,et al. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. , 1996, Journal of clinical pathology.